Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
KUNLUN ENERGY
00135
HK Stock MarketDetailed Quotes
BIOSTAR PHARM-B (02563)
- 4.350
- -0.130-2.90%
Trading May 22 14:27 CST
1.59BMarket Cap-10.90P/E (TTM)
4.350High4.350Low200Volume4.350Open4.480Prev Close870.00Turnover0.00%Turnover RatioLossP/E (Static)364.59MShares10.58052wk High2.15P/B1.59BFloat Cap2.40052wk Low--Dividend TTM364.59MShs Float39.500Historical High--Dividend LFY0.00%Range %2.400Historical Low4.350Avg Price200Lot Size--Div Yield TTM--Div Yield LFY
BIOSTAR PHARM-B (02563) Cash Flow
All
YOY
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||
| Earning before tax | 8.58%-131.44M | ---- | 24.19%-143.78M | ---- | -18.15%-189.64M | -64.47%-130.19M | ---160.51M | ---79.16M |
| Profit adjustment | ||||||||
| Interest (income) - adjustment | ---- | ---- | ---- | ---- | -361.14%-13.14M | -687.79%-10.32M | ---2.85M | ---1.31M |
| Investment loss (gain) | 27.17%-11.87M | ---- | ---16.3M | ---- | ---- | 33.33%-8.52M | ---10.85M | ---12.78M |
| Impairment and provisions: | 3,854.51%23.01M | ---- | 213.89%581.99K | ---- | -142.20%-511K | -183.23%-561K | --1.21M | --674K |
| -Impairmen of inventory (reversal) | ---- | ---- | ---- | ---- | --773K | --718K | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | ---- | ---- | ---- | -206.03%-1.28M | -289.76%-1.28M | --1.21M | --674K |
| -Other impairments and provisions | 3,854.51%23.01M | ---- | --581.99K | ---- | ---- | ---- | ---- | ---- |
| Revaluation surplus: | 109.64%47.48K | ---- | 94.58%-492.74K | ---- | ---9.1M | ---- | ---- | ---- |
| -Other fair value changes | 109.64%47.48K | ---- | 94.58%-492.74K | ---- | ---9.1M | ---- | ---- | ---- |
| Depreciation and amortization: | 8.28%10.62M | ---- | -7.69%9.81M | ---- | 1.14%10.62M | 3.30%8.05M | --10.5M | --7.79M |
| -Amortization of intangible assets | -56.47%512.7K | ---- | -2.26%1.18M | ---- | 2.47%1.21M | 3.31%904K | --1.18M | --875K |
| Financial expense | 265.27%9.94M | ---- | -10,648.57%-6.01M | ---- | -19.72%57K | -2.08%47K | --71K | --48K |
| Exchange Loss (gain) | ---- | ---- | ---- | ---- | 76.27%-4.65M | 72.77%-6.56M | ---19.6M | ---24.11M |
| Special items | ---- | ---- | ---- | ---- | -45.00%44.4M | -34.99%36.33M | --80.74M | --55.88M |
| Operating profit before the change of operating capital | ---- | ---- | ---- | ---- | -59.90%-161.96M | -110.96%-111.74M | ---101.29M | ---52.97M |
| Change of operating capital | ||||||||
| Inventory (increase) decrease | -324.40%-14.07M | ---- | -208.00%-3.31M | ---- | 136.35%3.07M | 154.97%3.56M | ---8.44M | ---6.47M |
| Accounts receivable (increase)decrease | -17.89%-15.72M | ---- | -152.86%-13.33M | ---- | 465.42%25.22M | 247.47%19.62M | ---6.9M | ---13.3M |
| Accounts payable increase (decrease) | -159.67%-30.88M | ---- | 1,428.11%51.74M | ---- | -88.01%3.39M | -132.80%-3.76M | --28.23M | --11.47M |
| prepayments (increase)decrease | ---- | ---- | ---- | ---- | -2,532.94%-8.95M | -7.05%-6.91M | ---340K | ---6.46M |
| Cash from business operations | ---- | ---- | ---- | ---- | -56.90%-139.24M | -46.51%-99.23M | ---88.74M | ---67.73M |
| Special items of business | 3.78%8.83M | -42.82%-99.21M | 173.75%8.51M | ---69.46M | -224.06%-11.54M | -223.65%-11.46M | --9.3M | --9.27M |
| Net cash from operations | -34.58%-151.52M | -42.82%-99.21M | 25.33%-112.59M | ---69.46M | -89.81%-150.78M | -89.34%-110.69M | ---79.44M | ---58.46M |
| Cash flow from investment activities | ||||||||
| Interest received - investment | ---- | ---- | ---- | ---- | --13.14M | ---- | ---- | ---- |
| Dividend received - investment | -29.20%11.1M | -51.95%6.59M | --15.68M | --13.72M | ---- | ---- | ---- | ---- |
| Decrease in deposits (increase) | ---- | ---- | ---- | ---- | 66.58%-72.5M | 67.78%-64.85M | ---216.92M | ---201.29M |
| Purchase of fixed assets | 86.72%-5.42M | 90.70%-2.6M | -46.57%-40.8M | ---27.95M | 12.62%-27.84M | -26.26%-25.33M | ---31.86M | ---20.06M |
| Purchase of intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---817K | ---757K |
| Recovery of cash from investments | -41.21%687.22M | -41.58%347.75M | 55.14%1.17B | --595.28M | -8.09%753.48M | -2.66%499.64M | --819.81M | --513.32M |
| Cash on investment | 44.66%-603.37M | 47.90%-250.1M | -103.80%-1.09B | ---480.01M | 25.38%-535M | 39.26%-280M | ---717M | ---461M |
| Adjustment items of investment business | ---- | ---- | ---- | --1K | ---- | ---- | ---- | ---- |
| Net cash from investment operations | 67.42%89.52M | 0.59%101.64M | -59.27%53.47M | --101.04M | 189.43%131.28M | 176.24%129.46M | ---146.79M | ---169.8M |
| Net cash before financing | -4.87%-61.99M | -92.30%2.43M | -203.12%-59.12M | --31.58M | 91.38%-19.5M | 108.22%18.76M | ---226.23M | ---228.26M |
| Cash flow from financing activities | ||||||||
| New borrowing | ---- | ---- | ---- | ---- | ---- | ---- | --70K | --70K |
| Refund | ---- | ---- | ---- | ---- | ---68K | ---68K | ---- | ---- |
| Interest paid - financing | ---- | ---- | ---- | ---- | 19.72%-57K | 2.08%-47K | ---71K | ---48K |
| Dividends paid - financing | 16.72%-46.31K | ---- | ---55.61K | ---- | ---- | ---- | ---- | ---- |
| Absorb investment income | ---- | ---- | --209.71M | ---- | ---- | ---- | ---- | ---- |
| Other items of the financing business | 22.26%-1.2M | ---- | ---1.55M | ---- | ---- | ---- | --4.66M | --4.66M |
| Net cash from financing operations | -100.60%-1.25M | ---- | 18,516.52%208.11M | ---- | -131.98%-1.13M | -124.35%-964K | --3.53M | --3.96M |
| Effect of rate | -299.89%-5.27M | -206.02%-3.59M | 290.32%2.64M | --3.39M | -109.64%-1.39M | -93.03%865K | --14.38M | --12.41M |
| Net Cash | -142.45%-63.24M | -92.30%2.43M | 822.09%148.99M | --31.58M | 90.73%-20.63M | 107.94%17.8M | ---222.69M | ---224.3M |
| Begining period cash | 398.10%189.71M | 34.68%458.45M | -36.63%38.09M | --340.4M | -77.61%60.11M | -77.61%60.11M | --268.42M | --268.42M |
| Cash at the end | -36.12%121.2M | 21.82%457.29M | 398.11%189.71M | --375.37M | -36.63%38.09M | 39.37%78.77M | --60.11M | --56.52M |
| Cash balance analysis | ||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | Daxin Certified Public Accountants (Special General Partnership) | -- | Daxin International (Hong Kong) Certified Public Accountants Limited (Special General Partnership) | -- | KPMG | -- | KPMG | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13, 2025 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
Food流油
Apr 14, 2025 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"